Watson investigational site 142 — Pittsburgh, Pennsylvania

Watson investigational site 142 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15206.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Watson investigational site 142 has participated in 1 clinical trials.

Therapeutic areas: Leiomyoma, Uterine Hemorrhage.

Sponsors: Allergan.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Watson investigational site 142?

Watson investigational site 142 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Watson investigational site 142 conducted?

Watson investigational site 142 has 1 clinical trials on record. Their work covers Leiomyoma, Uterine Hemorrhage.

Is Watson investigational site 142 accredited by Crixeo Health?

Watson investigational site 142 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Watson investigational site 142?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.